Twitter Announces Its Marketing Platform Program, A Rebranding Of Its Ads API
Posted 20 hours ago by Anthony Ha
Google To Confirm
Oppenheimer Sees Five Biotech Stocks to Buy With Potential 50% Upside, or More
Celldex Therapeutics Inc. (CLDX) focuses on developing therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines.
The company is expected to update its CDX-1135 in early February , which could be a huge catalyst. The Oppenheimer price target is set at $40.
Thanks ! After Reading Posts, Very Obvious Bashers Have NO Clue What's Going On With The Co.
I have used fly on wall for 6 months.. it's good but wouldn't pay for it again.
thanks for sharing- good post. this is the future folks.